NCT02233530

Brief Summary

This trials of cognitive stimulation therapy (CST) in Tanzania is part of the larger Identification and Intervention for Dementia in Elderly Africans (IDEA) study. The overall aim of the IDEA study is to set up and evaluate sustainable programmes to facilitate diagnosis of, and therapy for, people with dementia led by local communities in sub-Saharan Africa. The investigators seek to improve quality of life for people with dementia and their caregivers. Within this trial of CST, the investigators hypothesise that CST can significantly improve the quality of people with dementia and their carers living in Africa

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2014

Completed
2 days until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 8, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
5.8 years until next milestone

Results Posted

Study results publicly available

June 21, 2021

Completed
Last Updated

June 21, 2021

Status Verified

May 1, 2021

Enrollment Period

6 months

First QC Date

August 30, 2014

Results QC Date

March 10, 2021

Last Update Submit

May 26, 2021

Conditions

Keywords

DementiaCognitive Stimulation TherapyQuality of lifeCognitive impairmentAfricaTanzaniaNigeriaLow- and Middle-income countriesNon-pharmacological interventionTask-shiftingCognitive screening

Outcome Measures

Primary Outcomes (2)

  • World Health Organization Brief Quality of Life Measure (WHOQOL-Bref)

    Quality of life assessment in patients and carers. The minimum score is 4 and the maximum 20, with a higher score signifying better quality of life.

    Baseline

  • World Health Organization Brief Quality of Life Measure (WHOQOL-Bref)

    Quality of life assessment in patients and carers. The minimum score is 4 and the maximum 20, with a higher score signifying better quality of life.

    An average of eight weeks from baseline

Secondary Outcomes (15)

  • WHOQOL Bref

    An average of twelve weeks from baseline

  • IDEA Cognitive Screen

    Baseline

  • IDEA Cognitive Screen

    An average of eight weeks from baseline

  • IDEA Cognitive Screen

    An average of twelve weeks from baseline

  • Hospital Anxiety and Depression Scale (HADS)

    Baseline

  • +10 more secondary outcomes

Study Arms (1)

CST intervention

EXPERIMENTAL

Outcomes at baseline will be compared with those immediately post intervention and at four weeks post-intervention. In accordance with the CST manual protocol, patients will be allocated to groups to ensure a spread of abilities and ensure inclusivity. No group contains only one individual of a particular religion or gender, such that they may feel left out. The investigators will allocate patients to groups to avoid excessive travel to the group meeting place, participants may be allocated to a group based on their geographical location. Individuals will be allocated to groups based on religion, gender and geographical location.

Behavioral: CST intervention

Interventions

The CST intervention comprises 14 sessions lasting 1-2 hours across 7 weeks. The CST manual has been adapted for use in this setting by members of our study team. Each session has a theme. Activities include tasks aimed at engaging participants in cognitive and physical tasks designed to improve quality of life. Sessions will be led and facilitated by a study nurse or occupational therapist. The sessions will be held at a local health centre of village hall.

CST intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Anyone with dementia living within the study site

You may not qualify if:

  • The participant and the family should have consented to take part in the study.
  • Unable to travel to the centre where the CST sessions will be held due to physical impairment (e.g. bedbound or immobile)
  • After assessment by the study doctor, deemed unable to engage in CST sessions (e.g. follow instructions and participate in activities) due to severe physical or cognitive impairment.
  • Profound deafness
  • Total blindness
  • Aphasia - they should be able to understand verbal communication and communicate verbally (mild impairments are acceptable).
  • The participant should be able to sit in a group setting for 1 hour.
  • There should not be agitation, depression or psychosis to an extent that the person would not be able to tolerate spending time with other people in a group setting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lalupon

Lalupon, Oyo State, Nigeria

Location

Related Publications (1)

  • Gray WK, Paddick SM, Kisoli A, Dotchin CL, Longdon AR, Chaote P, Samuel M, Jusabani AM, Walker RW. Development and Validation of the Identification and Intervention for Dementia in Elderly Africans (IDEA) Study Dementia Screening Instrument. J Geriatr Psychiatry Neurol. 2014 Jun;27(2):110-8. doi: 10.1177/0891988714522695. Epub 2014 Feb 26.

    PMID: 24578459BACKGROUND

MeSH Terms

Conditions

DementiaCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Results Point of Contact

Title
Dr Adesola Ogunniyi
Organization
University of Ibadan, Ibadan, Nigeria

Study Officials

  • Adesola Ogunniyi, MD

    University of Ibadan, Nigeria

    PRINCIPAL INVESTIGATOR
  • Akin Adebiyi

    University of Ibadan

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr Willliam Gray

Study Record Dates

First Submitted

August 30, 2014

First Posted

September 8, 2014

Study Start

September 1, 2014

Primary Completion

March 1, 2015

Study Completion

September 1, 2015

Last Updated

June 21, 2021

Results First Posted

June 21, 2021

Record last verified: 2021-05

Locations